ATE125551T1 - Amidderivate vom antibiotikum a 40926. - Google Patents

Amidderivate vom antibiotikum a 40926.

Info

Publication number
ATE125551T1
ATE125551T1 AT92915890T AT92915890T ATE125551T1 AT E125551 T1 ATE125551 T1 AT E125551T1 AT 92915890 T AT92915890 T AT 92915890T AT 92915890 T AT92915890 T AT 92915890T AT E125551 T1 ATE125551 T1 AT E125551T1
Authority
AT
Austria
Prior art keywords
antibiotic
amide derivatives
alkylaminocarbonyl
substituent
staplylococci
Prior art date
Application number
AT92915890T
Other languages
English (en)
Inventor
Adriano Malabarba
Romeo Ciabatti
Gianbattista Panzone
Alessandra Maria Marazzi
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26128958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE125551(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE125551T1 publication Critical patent/ATE125551T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT92915890T 1991-07-29 1992-07-14 Amidderivate vom antibiotikum a 40926. ATE125551T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91112685 1991-07-29
EP92109906 1992-06-12

Publications (1)

Publication Number Publication Date
ATE125551T1 true ATE125551T1 (de) 1995-08-15

Family

ID=26128958

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92915890T ATE125551T1 (de) 1991-07-29 1992-07-14 Amidderivate vom antibiotikum a 40926.

Country Status (24)

Country Link
EP (2) EP0596929B1 (de)
JP (1) JP3418762B2 (de)
KR (1) KR100242682B1 (de)
AT (1) ATE125551T1 (de)
AU (1) AU666862B2 (de)
BG (1) BG61124B2 (de)
CA (1) CA2109601C (de)
CZ (1) CZ285703B6 (de)
DE (1) DE69203724T2 (de)
DK (1) DK0596929T3 (de)
ES (1) ES2075709T3 (de)
FI (1) FI112662B (de)
GR (1) GR3017897T3 (de)
HU (2) HU223946B1 (de)
IE (1) IE68420B1 (de)
IL (1) IL102623A (de)
MX (1) MX9204394A (de)
NO (1) NO314150B1 (de)
NZ (1) NZ243735A (de)
PL (1) PL171813B1 (de)
RU (1) RU2125058C1 (de)
TW (1) TW218021B (de)
UA (1) UA41283C2 (de)
WO (1) WO1993003060A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
RU2145609C1 (ru) * 1994-01-28 2000-02-20 Эли Лилли Энд Компани Производные гликопептида или их соли, способ получения, фармацевтическая композиция
DE69633234T2 (de) * 1995-07-05 2005-09-15 Aventis Bulk S.P.A. Reinigung von dalbeheptide-antibiotika mittels isoelektrofokussierung
DK0912604T3 (da) * 1996-04-23 2002-03-25 Biosearch Italia Spa Forbedret kemisk fremgangsmåde til fremstilling af amidderivater af A 40926 antibiotikum
US6004959A (en) * 1996-05-30 1999-12-21 Hoechst Marion Roussel, Inc. Alkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitors
CZ301184B6 (cs) 1998-12-23 2009-12-02 Theravance, Inc. Glykopeptidový derivát a farmaceutické prostredky, které jej obsahují
AR021964A1 (es) * 1998-12-23 2002-09-04 Theravance Inc Un compuesto glicopeptidico, composiciones farmaceuticas que los contienen y uso de dichos compuestos glicopeptidicos para la manufactura de un medicamento antibacteriano.
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
TWI312785B (en) 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
KR100478533B1 (ko) * 2002-07-30 2005-03-28 한국수력원자력 주식회사 레이저를 이용한 탈륨 동위원소 분리방법
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US6900175B2 (en) 2002-11-18 2005-05-31 Vicuron Pharmaceuticals Inc. Methods of administering dalbavancin for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
JP2006528704A (ja) 2003-05-27 2006-12-21 セラヴァンス インコーポレーテッド グリコペプチド抗細菌剤と組み合わせたポリエンマクロライド抗真菌剤の使用
DE602004010915T2 (de) 2003-07-22 2008-12-11 Theravance, Inc., South San Francisco Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel
EP1818340A4 (de) 2004-11-29 2009-02-25 Univ Nagoya Nat Univ Corp Antibiotische monomere glykopeptidderivate
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
CA2710417A1 (en) 2007-12-26 2009-07-02 Shionogi & Co., Ltd. Glycosylated glycopeptide antibiotic derivatives
WO2022148868A1 (en) * 2021-01-11 2022-07-14 Xellia Pharmaceuticals Aps Synthesis process

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608809D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Antibiotic
GB8726859D0 (en) * 1987-11-17 1987-12-23 Lepetit Spa 22-dechlorotei-coplanins
EP0376041B1 (de) * 1988-12-27 1996-02-28 GRUPPO LEPETIT S.p.A. C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen
GB2231846B (en) * 1989-05-25 1993-02-24 Hadlum Brothers Ltd A hand held carrier
DE69117304T2 (de) * 1990-12-05 1996-08-29 Lepetit Spa 38-decarboxy-38-hydroxymethylderivate von teicoplaninantibiotika, und verfahren zu deren herstellung
ATE145921T1 (de) * 1991-03-27 1996-12-15 Lepetit Spa Esterderivate von antibiotikum-a 40926

Also Published As

Publication number Publication date
FI940394A0 (fi) 1994-01-26
DK0596929T3 (da) 1995-09-11
NO314150B1 (no) 2003-02-03
IE68420B1 (en) 1996-06-12
CA2109601A1 (en) 1993-02-18
KR100242682B1 (ko) 2000-02-01
BG61124B2 (bg) 1996-11-29
ES2075709T3 (es) 1995-10-01
TW218021B (de) 1993-12-21
CA2109601C (en) 2002-07-02
PL171813B1 (pl) 1997-06-30
IL102623A0 (en) 1993-01-14
FI112662B (fi) 2003-12-31
NO934722D0 (no) 1993-12-20
DE69203724D1 (de) 1995-08-31
HU223946B1 (hu) 2005-03-29
GR3017897T3 (en) 1996-01-31
JPH06509347A (ja) 1994-10-20
WO1993003060A1 (en) 1993-02-18
HU211347A9 (en) 1995-11-28
CZ285703B6 (cs) 1999-10-13
CZ19294A3 (en) 1994-11-16
HU9400256D0 (en) 1994-05-30
EP0596929A1 (de) 1994-05-18
FI940394A (fi) 1994-01-26
AU2326292A (en) 1993-03-02
NO934722L (no) 1994-02-14
IL102623A (en) 1996-10-16
DE69203724T2 (de) 1996-01-18
JP3418762B2 (ja) 2003-06-23
HUT66080A (en) 1994-09-28
IE922451A1 (en) 1993-02-10
UA41283C2 (uk) 2001-09-17
AU666862B2 (en) 1996-02-29
NZ243735A (en) 1995-01-27
EP0596929B1 (de) 1995-07-26
MX9204394A (es) 1993-01-29
EP0525499A1 (de) 1993-02-03
RU2125058C1 (ru) 1999-01-20

Similar Documents

Publication Publication Date Title
ATE125551T1 (de) Amidderivate vom antibiotikum a 40926.
ATE190983T1 (de) Neue tetrapeptidderivate
DE69434136D1 (de) Dolastatin-derivate
NO2006018I1 (no) Entekavir:(2-amino-1,9-dihydro-9Ä(1S,3R,4S)-4hydroksy-3-(hydroksymetyl)-2-metylencyklopentylÜ-6H-purin-6-on og hydrater derav, saerlig monohydrat
ATE157368T1 (de) 6-0-methylerythromycin a-derivat
DE69835841D1 (de) Hydrazonderivate
RU94013457A (ru) Амидные производные антибиотика а 40926
PT825186E (pt) Derivados de 2-aminobenzazepina e sua utilizacao para o tratamento da imunossupressao
ATE99298T1 (de) 1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung.
ATE90685T1 (de) Disaccharidderivate.
ATE190308T1 (de) Epoxycyclohexendionderivat
FI963568A0 (fi) Peptidijohdannaisia
ATE197953T1 (de) Pyrrolo(4,3,2-de)chinolin-derivat
DE69017763D1 (de) Angolamycin-Derivate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee